Skip to main content
OpenTrials
Completed

NCT Number: NCT07506252

Influence of Hydration Status on the Yield of Injectable Platelet-Rich Fibrin

Due to the current lack of evidence regarding the influence of fluid intake on the amount of leukocyte- and platelet-rich fibrin fraction present in blood samples, this study aims to investigate the positive influence of this factor on the body's own matrix.

Platelet-rich fibrin, a fibrin-rich autologous matrix obtained from autologous blood via centrifugation, contains not only fibrin but also important growth factors and a large number of white blood cells, all of which make a significant contribution to tissue regeneration. The obtained fibrin matrix can be used as a membrane, as a clot (A-PRF), or as a liquid (i-PRF) to positively influence the healing process.

The novelty of this work lies in shifting the focus from purely technical centrifugation parameters to a patient-centered, easily modifiable biological variable. Hydration status represents a low-cost, non-invasive, and immediately applicable strategy to optimize autologous blood concentrates. These findings are directly relevant to clinicians seeking to enhance the predictability and efficiency of PRF-based regenerative procedures in implant dentistry.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Medical University of Graz

Graz, Styria, 8010, Austria

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy adults

Exclusion criteria

  • coagulation disorders
  • anticoagulant medication
  • pregnancy
  • acute infections
  • systemic diseases with the potential to affect wound healing or blood composition

Treatment and study plan

Hydration following a drinking protocol

Behavioral

Participants followed a drinking protocol the day before the measurement to reach euhydration

Primary outcomes

  1. PRF-Volume

    Time frame: 3 visits, 3 weeks

    Volume (ml) of i-PRF obtained from each 10 ml blood sample with low speed centrifugation

Secondary outcomes

  1. PRF yield and height

    Time frame: 3 visits, 3 weeks

    Correlation of PRF yield in ml and height in cm

  2. PRF yield and weight

    Time frame: 3 visits, 3 weeks

    Correlation of PRF yield in ml and weight in kg

Sponsors and collaborators

Lead sponsor

Medical University of Graz

Other

Registry information

Official study title

Influence of the Drinking Amount on the Autologous Blood in the Centrifuge Contained Fibrin Matrix - Platelet-rich Fibrin A Randomized Controlled Pilot Study

Acronym: T-PRF

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Apr 1, 2026
Registry last updated
Apr 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.